company background image
JYNT logo

Joint NasdaqCM:JYNT Rapport sur les actions

Dernier prix

US$11.42

Capitalisation boursière

US$172.2m

7D

0.5%

1Y

17.6%

Mise à jour

19 Aug, 2024

Données

Finances de l'entreprise +

The Joint Corp.

NasdaqCM:JYNT Rapport sur les actions

Capitalisation boursière : US$172.2m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

JYNT Aperçu des actions

The Joint Corp. exploite et franchise des cliniques chiropratiques aux États-Unis.

JYNT analyse fondamentale
Score flocon de neige
Évaluation2/6
Croissance future3/6
Performances passées0/6
Santé financière6/6
Dividendes0/6

The Joint Corp. Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Joint
Historique des cours de bourse
Prix actuel de l'actionUS$11.42
Plus haut sur 52 semainesUS$17.82
Plus bas sur 52 semainesUS$7.31
Bêta1.6
1Variation sur 1 mois-18.43%
Variation sur 3 mois-30.15%
Variation sur 1 an17.61%
3Variation sur 3 ans-87.62%
Variation sur 5 ans-33.60%
Évolution depuis l'introduction en bourse73.56%

Nouvelles et mises à jour récentes

The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 05
The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Jul 17
Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Recent updates

The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 05
The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Jul 17
Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

May 04
Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

Mar 10
The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Feb 12
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Jun 17
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

Jan 04
Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Oct 27
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

The Joint Corp. Can Relieve You From High Inflation Pain

Oct 17

The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape

Aug 05

These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Jul 22
These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Jun 29
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Jun 14
Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 03
Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Feb 23
Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Feb 08
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story

Jan 30

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Jan 24
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?

Jan 08
What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?

Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?

Nov 23
Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?

Is Joint (NASDAQ:JYNT) A Risky Investment?

Nov 08
Is Joint (NASDAQ:JYNT) A Risky Investment?

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Oct 21
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?

Oct 05
Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?

The Joint Corporation: Time To Take Some Profits

Aug 10

Is Joint (NASDAQ:JYNT) Using Too Much Debt?

Aug 02
Is Joint (NASDAQ:JYNT) Using Too Much Debt?

The Joint Corp. Has Rallied By 400% Since We Bought, But It's Time To Let It Go

Jul 23

Rendement pour les actionnaires

JYNTUS HealthcareUS Marché
7D0.5%2.9%4.9%
1Y17.6%11.5%25.6%

Rendement vs Industrie: JYNT a dépassé le secteur US Healthcare qui a rapporté 11.6 % au cours de l'année écoulée.

Rendement vs marché: JYNT underperformed the US Market which returned 24.7% over the past year.

Volatilité des prix

Is JYNT's price volatile compared to industry and market?
JYNT volatility
JYNT Average Weekly Movement6.5%
Healthcare Industry Average Movement7.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.2%

Cours de l'action stable: JYNT's share price has been volatile over the past 3 months.

Volatilité au fil du temps: JYNT's weekly volatility (6%) has been stable over the past year.

À propos de l'entreprise

FondéeSalariésPDGSite web
2010619Peter Holtwww.thejoint.com

The Joint Corp. exploite et franchise des cliniques chiropratiques aux États-Unis. La société opère dans deux segments, les cliniques d'entreprise et les opérations de franchise. The Joint Corp. a été constituée en 2010 et son siège social se trouve à Scottsdale, en Arizona.

The Joint Corp. Résumé des fondamentaux

Comment les bénéfices et les revenus de Joint se comparent-ils à sa capitalisation boursière ?
JYNT statistiques fondamentales
Capitalisation boursièreUS$172.16m
Bénéfices(TTM)-US$14.41m
Recettes(TTM)US$120.07m

1.4x

Ratio P/S

-11.9x

Ratio P/E

Le site JYNT est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
JYNT compte de résultat (TTM)
RecettesUS$120.07m
Coût des recettesUS$11.02m
Marge bruteUS$109.05m
Autres dépensesUS$123.46m
Les revenus-US$14.41m

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)-0.96
Marge brute90.82%
Marge bénéficiaire nette-12.00%
Ratio dettes/capitaux propres0%

Quelles ont été les performances à long terme de JYNT?

Voir les performances historiques et les comparaisons